Cell cycle synchronization of human umbilical cord mesenchymal stromal cells improves therapeutic efficacy in acute colitis, according to recent findings. Researchers administered these pretreated cells via tail vein and intraperitoneal injection to a mouse model, observing reduced inflammatory cell infiltration and promoted histological restoration compared to non-synchronized cell treatments.
Cell Cycle Synchronization Protocols for Stromal Cells
Under standard laboratory culture conditions, cell populations naturally exist across various phases of the cell cycle. To capture the S phase, the team employed a starvation-double thymidine block method, which successfully synchronized roughly 60% of the cells.
Progressing the cells further required specific handling after the initial block. Culturing those S-phase-synchronized cells in a complete medium for four to eight hours yielded approximately 40% enrichment into the G2/M phase. Throughout these transitions, the study confirmed that cell cycle synchronization procedures did not significantly induce unwanted cellular senescence or apoptosis.
Biological Characteristics Across Different Phases
Evaluating the functional profiles of the synchronized cells revealed distinct physiological differences depending on their active phase. G0/G1-phase cells exhibited the lowest proliferation potential among the groups. Conversely, cells in both the S phase and the G2/M phase displayed markedly increased proliferative capacity.
Factor secretion patterns also shifted across the cycle. S-phase cells secreted lower amounts of transforming growth factor-beta (TGF-β), whereas prostaglandin E2 (PGE2) secretion showed a steady upward trend moving from the G0/G1 phase through the S phase and into the G2/M phase. While the synchronized cells did not significantly alter Th1 and Th17 cell populations, they demonstrated a targeted modulatory effect on regulatory T cells across peripheral blood, spleen, and mesenteric lymph nodes.
Therapeutic Efficacy in Acute Colitis Models
To test real-world application, investigators established an acute colitis mouse model using a 5% dextran sulfate sodium solution. Disease Activity Index scores were recorded daily, showing tangible metrics of recovery. On day seven of the protocol, colon length measurements confirmed that synchronization-associated pretreatment significantly attenuated the colon shortening typically caused by the disease.
Histopathological analysis using H&E, PAS, and MPO staining demonstrated reduced inflammatory infiltration and supported overall mucosal healing. The data indicate that the act of cell cycle synchronization itself—rather than dependence on any single, isolated cell cycle phase—drives the enhanced therapeutic efficacy observed in treating acute colitis.
Frequently Asked Questions
How were the stem cells synchronized into the G0/G1 phase?
Researchers used a serum starvation method, which successfully synchronized roughly 80% to 90% of the human umbilical cord mesenchymal stromal cells into the G0/G1 phase.
What method achieved S-phase synchronization?
The study employed a starvation-double thymidine block method to capture and synchronize approximately 60% of the cell population in the S phase.
How was the acute colitis model created for the study?
Investigators established the murine model using a 5% dextran sulfate sodium solution, administering the treated stem cells on the first and fifth days of the experimental timeline.